Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
25.02.26
/
50%
€162.75
Target price
25.02.27
€212.10
Performance (%)
-1.20%
Price
27.02.26
€160.80
Summary
This prediction is currently active. With a performance of -1.20%, the BUY prediction for Jazz Pharmaceuticals plc by Wells_Fargo___Compan is down slightly. This prediction currently runs until 25.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Jazz Pharmaceuticals plc | -1.20% |
| iShares Core DAX® | 1.232% |
| iShares Nasdaq 100 | 0.695% |
| iShares Nikkei 225® | 2.085% |
| iShares S&P 500 | 0.419% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
3.11%
27.02.26
27.02.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.00
13.02.25
13.02.25
€163.54
13.02.26
13.02.26
6.50%
14.02.26
14.02.26